연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1877. TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials.
Lee DW, Jang MJ, Lee KH, Cho EJ, Lee JH, Yu SJ, Kim YJ, Yoon JH, Kim TY, Han SW, Oh DY, Im SA, Kim TY.
Br J Cancer. 2016 Nov 8;115(10):1201-1205. doi: 10.1038/bjc.2016.322. Epub 2016 Oct 13.
Link
1876. Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database.
Shin S, Park CM, Kwon H, Lee KH.
BMC Cancer. 2016 Jul 11;16:443. doi: 10.1186/s12885-016-2482-z.
Link
1875. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
Suh KJ, Ryu HS, Lee KH, Kim H, Min A, Kim TY, Yang Y, Moon HG, Han SW, Oh DY, Han W, Park IA, Noh DY, Im SA.
Breast Cancer Res Treat. 2016 Jul;158(2):233-41. doi: 10.1007/s10549-016-3869-x. Epub 2016 Jun 21.
Link
1874. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
Nutr Cancer. 2016 Jul;68(5):750-5. doi: 10.1080/01635581.2016.1180413. Epub 2016 Jun 9.
Link
1873. Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells.
Jung KO, Youn HW, Lee CH, Kang KW, Chung JK.
Oncotarget. 2016 Dec 27. doi: 10.18632/oncotarget.14247. [Epub ahead of print]
Link
1872. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T, Na J, Kim YI, Chang DY, Kim YI, Kim H, Moon HE, Kang KW, Lee DS, Chung JK, Kim SS, Suh-Kim H, Paek SH, Youn HW.
Theranostics. 2016 Jun 17;6(10):1477-90. doi: 10.7150/thno.14158. eCollection 2016.
Link
1871. A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM.
Jung KO, Youn HW, Kim SH, Kim YH, Kang KW, Chung JK.
Biochem Biophys Res Commun. 2016 Aug 26;477(3):483-9. doi: 10.1016/j.bbrc.2016.06.068. Epub 2016 Jun 15.
Link
1870. Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.
Ryu J, Koh Y, Park H, Kim DY, Kim DC, Byun JM, Lee HJ, Yoon SS.
Mol Cells. 2016 Dec;39(12):898-908. doi: 10.14348/molcells.2016.0210. Epub 2016 Dec 21.
Link
1869. MCM7 polymorphisms associated with the AML relapse and overall survival.
Lee JS, Cheong HS, Koh Y, Ahn KS, Shin HD, Yoon SS.
Ann Hematol. 2017 Jan;96(1):93-98. doi: 10.1007/s00277-016-2844-2. Epub 2016 Nov 12.
Link
1868. SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
Kim JH, Lee C, Cheong HS, Koh Y, Ahn KS, Kim HL, Shin HD, Yoon SS.
Cancer Chemother Pharmacol. 2016 Sep;78(3):533-40. doi: 10.1007/s00280-016-3103-x. Epub 2016 Jul 15.
Link